Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.
|
Circulation
|
1997
|
2.95
|
2
|
Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes.
|
Emerg Med J
|
2004
|
2.71
|
3
|
Transforming growth factor-beta1 gene polymorphisms and coronary artery disease.
|
Clin Sci (Lond)
|
1998
|
2.68
|
4
|
Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease.
|
Circulation
|
1999
|
2.17
|
5
|
Mechanisms of angina pectoris in syndrome X.
|
J Am Coll Cardiol
|
1991
|
2.16
|
6
|
Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris.
|
N Engl J Med
|
1990
|
1.89
|
7
|
Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina.
|
N Engl J Med
|
1991
|
1.87
|
8
|
Role of adenosine in pathogenesis of anginal pain.
|
Circulation
|
1990
|
1.60
|
9
|
Rarefaction of skin capillaries in patients with anginal chest pain and normal coronary arteriograms.
|
Eur Heart J
|
2001
|
1.58
|
10
|
Coronary artery spasm and vasoconstriction. The case for a distinction.
|
Circulation
|
1990
|
1.55
|
11
|
Angiographic stenosis progression and coronary events in patients with 'stabilized' unstable angina.
|
Circulation
|
1995
|
1.54
|
12
|
Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression.
|
Eur Heart J
|
2001
|
1.54
|
13
|
Effect of theophylline on exercise-induced myocardial ischaemia.
|
Lancet
|
1989
|
1.52
|
14
|
Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris.
|
J Am Coll Cardiol
|
1998
|
1.48
|
15
|
C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men.
|
Eur Heart J
|
2000
|
1.46
|
16
|
Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism.
|
Eur Heart J
|
1996
|
1.46
|
17
|
Reactivity of proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina pectoris.
|
Am J Cardiol
|
1991
|
1.45
|
18
|
The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina.
|
Am J Cardiol
|
1982
|
1.44
|
19
|
Effect of magnesium sulphate in patients with unstable angina. A double blind, randomized, placebo-controlled study.
|
Eur Heart J
|
1997
|
1.41
|
20
|
Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome.
|
Int J Cardiol
|
2010
|
1.41
|
21
|
Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin.
|
Heart
|
2006
|
1.40
|
22
|
Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study.
|
Eur Heart J
|
1996
|
1.39
|
23
|
Variability of coronary blood flow reserve assessed by Doppler catheter after successful thrombolysis in patients with acute myocardial infarction.
|
Am Heart J
|
1993
|
1.39
|
24
|
Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina.
|
Circulation
|
2001
|
1.31
|
25
|
Absence of myocardial dysfunction during stress in patients with syndrome X.
|
J Am Coll Cardiol
|
1991
|
1.23
|
26
|
Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone.
|
Circulation
|
1981
|
1.22
|
27
|
Clinical factors and angiographic features associated with premature coronary artery disease.
|
Chest
|
1995
|
1.22
|
28
|
Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina.
|
Circulation
|
1986
|
1.21
|
29
|
Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris.
|
Am J Cardiol
|
2000
|
1.17
|
30
|
The role of neopterin in atherogenesis and cardiovascular risk assessment.
|
Curr Med Chem
|
2009
|
1.15
|
31
|
Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X.
|
Circulation
|
1994
|
1.11
|
32
|
Chlamydia pneumoniae infection and coronary artery disease.
|
J Am Coll Cardiol
|
1999
|
1.08
|
33
|
CD14 and toll-like receptor 4: a link between infection and acute coronary events?
|
Heart
|
2004
|
1.08
|
34
|
Different susceptibility to myocardial ischemia provoked by hyperventilation and cold pressor test in exertional and variant angina pectoris.
|
Am J Cardiol
|
1985
|
1.07
|
35
|
Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.
|
Circulation
|
1986
|
1.03
|
36
|
Assessment of quality of life in patients with chest pain and normal coronary arteriogram (syndrome X) using a specific questionnaire.
|
Clin Cardiol
|
1999
|
1.02
|
37
|
Endothelial dysfunction, subangiographic atheroma, and unstable symptoms in patients with chest pain and normal coronary arteriograms.
|
Clin Cardiol
|
2000
|
0.99
|
38
|
Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X).
|
Clin Cardiol
|
2001
|
0.98
|
39
|
Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes.
|
Heart
|
2004
|
0.96
|
40
|
Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease.
|
Am J Cardiol
|
1993
|
0.95
|
41
|
Pain threshold and tolerance in women with syndrome X and women with stable angina pectoris.
|
Am J Cardiol
|
1987
|
0.95
|
42
|
Abnormal autonomic control of the cardiovascular system in syndrome X.
|
Am J Cardiol
|
1994
|
0.94
|
43
|
Inflammatory systemic biomarkers in setting acute coronary syndromes--effects of the diurnal variation.
|
Curr Drug Targets
|
2009
|
0.93
|
44
|
High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy.
|
Am J Cardiol
|
2001
|
0.93
|
45
|
Heart rate variability depression in patients with unstable angina.
|
Am Heart J
|
1995
|
0.92
|
46
|
Induction of coronary artery spasm by a direct local action of ergonovine.
|
Circulation
|
1987
|
0.91
|
47
|
Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome X.
|
Am J Cardiol
|
2000
|
0.90
|
48
|
Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia.
|
Am J Cardiol
|
1985
|
0.88
|
49
|
Effects of beta 2-adrenoceptor stimulation on exercise-induced myocardial ischemia.
|
Am J Cardiol
|
1991
|
0.88
|
50
|
Transient myocardial ischemia during daily life in patients with syndrome X.
|
Am J Cardiol
|
1986
|
0.88
|
51
|
Coronary vasomotor effects of serotonin in patients with angina. Relation to coronary stenosis morphology.
|
Circulation
|
1993
|
0.88
|
52
|
Mixed angina pectoris.
|
Am J Cardiol
|
1985
|
0.88
|
53
|
Serum neopterin in acute coronary syndromes.
|
Lancet
|
1997
|
0.87
|
54
|
Transient autonomic dysfunction precedes ST-segment depression in patients with syndrome X.
|
Am J Cardiol
|
1996
|
0.87
|
55
|
Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty.
|
Br Heart J
|
1995
|
0.86
|
56
|
Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy.
|
Heart
|
1996
|
0.85
|
57
|
Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms.
|
Eur Heart J
|
1998
|
0.85
|
58
|
Serum neopterin and complex stenosis morphology in patients with unstable angina.
|
J Am Coll Cardiol
|
2000
|
0.85
|
59
|
Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools.
|
J Intern Med
|
2007
|
0.85
|
60
|
Syndrome X in women is associated with oestrogen deficiency.
|
Eur Heart J
|
1995
|
0.85
|
61
|
Emotional triggering and low socio-economic status as determinants of depression following acute coronary syndrome.
|
Psychol Med
|
2011
|
0.84
|
62
|
Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms.
|
J Am Coll Cardiol
|
1999
|
0.83
|
63
|
Creatine kinase MB isoforms: sensitive markers of ischemic myocardial damage.
|
Clin Chem
|
1994
|
0.83
|
64
|
Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: pathophysiological implications in coronary disease.
|
Endothelium
|
1998
|
0.83
|
65
|
Increased QT dispersion in patients with Prinzmetal's variant angina and cardiac arrest.
|
Cardiovasc Res
|
2001
|
0.83
|
66
|
Histological patterns of atherosclerotic plaques in unstable angina patients vary according to clinical presentation.
|
Heart
|
1998
|
0.82
|
67
|
Complex stenosis morphology predicts late reocclusion during follow-up after myocardial infarction in patients with patent infarct-related coronary arteries.
|
Am Heart J
|
1998
|
0.82
|
68
|
Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma.
|
Br J Cancer
|
1998
|
0.82
|
69
|
Increased serum neopterin: a marker of coronary artery disease activity in women.
|
Heart
|
2000
|
0.82
|
70
|
Regional variations in ETA/ETB binding sites in human coronary vasculature.
|
J Cardiovasc Pharmacol
|
1995
|
0.81
|
71
|
Enhanced vasomotor responses of complex coronary stenoses to acetylcholine in stable angina pectoris.
|
Am J Cardiol
|
1995
|
0.81
|
72
|
Abnormal uptake and washout of thallium-201 in patients with syndrome X and normal-appearing scans.
|
Am J Cardiol
|
1995
|
0.81
|
73
|
Atherosclerotic plaque regression - the role of statin therapy.
|
Drugs Today (Barc)
|
2010
|
0.81
|
74
|
Negative stress echocardiographic responses in normotensive and hypertensive patients with angina pectoris, positive exercise stress testing, and normal coronary arteriograms.
|
Heart
|
2000
|
0.81
|
75
|
Differential progression of complex and smooth stenoses within the same coronary tree in men with stable coronary artery disease.
|
J Am Coll Cardiol
|
1995
|
0.80
|
76
|
Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X).
|
Heart
|
1997
|
0.80
|
77
|
Effects of aminophylline on cardiac function and regional myocardial perfusion: implications regarding its antiischemic action.
|
Am Heart J
|
1994
|
0.80
|
78
|
Preangioplasty complicated coronary stenosis morphology as a predictor of restenosis.
|
Am Heart J
|
1992
|
0.80
|
79
|
Relation between stimulation site of cardiac afferent nerves by adenosine and distribution of cardiac pain: results of a study in patients with stable angina.
|
J Am Coll Cardiol
|
1992
|
0.80
|
80
|
Peroxisome proliferator activated receptor gamma: a potential therapeutic target in the management of ischaemic heart disease.
|
Heart
|
2001
|
0.80
|
81
|
Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome.
|
Eur Heart J
|
1998
|
0.80
|
82
|
Antioxidant treatment for heart failure: friend or foe?
|
QJM
|
2008
|
0.80
|
83
|
Heart rate response during exercise testing and ambulatory ECG monitoring in patients with syndrome X.
|
Am Heart J
|
1991
|
0.80
|
84
|
The natural history of unheralded complex coronary plaques.
|
J Am Coll Cardiol
|
1996
|
0.79
|
85
|
The role of T and B cells in atherosclerosis: potential clinical implications.
|
Curr Pharm Des
|
2011
|
0.79
|
86
|
Angiographic progression in patients with angina pectoris and normal or near normal coronary angiograms who are restudied due to unstable symptoms.
|
Eur Heart J
|
1998
|
0.79
|
87
|
Effects of balloon occlusion during percutaneous coronary intervention on circulating Ischemia Modified Albumin and transmyocardial lactate extraction.
|
Heart
|
2006
|
0.79
|
88
|
Variability of results during repeat exercise stress testing in patients with stable angina pectoris: role of dynamic coronary flow reserve.
|
Am Heart J
|
1986
|
0.78
|
89
|
Comparative effects of theophylline and isosorbide dinitrate on exercise capacity in stable angina pectoris, and their mechanisms of action.
|
Am J Cardiol
|
1989
|
0.78
|
90
|
Mechanisms and significance of cardiac ischemic pain.
|
Prog Cardiovasc Dis
|
1992
|
0.78
|
91
|
Electrocardiographic diagnosis of transient myocardial ischemia. Sensitivity, specificity, and practical significance.
|
Ann N Y Acad Sci
|
1990
|
0.78
|
92
|
Atheromatous plaque location and arterial remodelling.
|
Eur Heart J
|
2003
|
0.78
|
93
|
Antianginal and anti-ischaemic efficacy of tedisamil, a potassium channel blocker.
|
Heart
|
2000
|
0.78
|
94
|
Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X.
|
Am J Cardiol
|
1989
|
0.78
|
95
|
Effect of alpha1-adrenoceptor blockade on coronary vasodilator reserve in cardiac syndrome X.
|
J Cardiovasc Pharmacol
|
1999
|
0.78
|
96
|
Provocation of coronary spasm by dopamine in patients with active variant angina pectoris.
|
Circulation
|
1986
|
0.78
|
97
|
Usefulness of Holter monitoring to improve the sensitivity of exercise testing in determining the degree of myocardial revascularization after coronary artery bypass grafting for stable angina pectoris.
|
Am J Cardiol
|
1987
|
0.78
|
98
|
Myocardial ischemia during ergonovine testing: different susceptibility to coronary vasoconstriction in patients with exertional and variant angina.
|
Circulation
|
1984
|
0.77
|
99
|
Aggressive pattern of angina after successful coronary angioplasty: the role of clinical and angiographic factors.
|
Eur Heart J
|
1995
|
0.77
|
100
|
Myocardial beta-adrenoceptor density and plasma catecholamines in syndrome X.
|
Am J Cardiol
|
1996
|
0.77
|
101
|
Differential progression of complex culprit stenoses in patients with stable and unstable angina pectoris.
|
J Am Coll Cardiol
|
1996
|
0.77
|
102
|
Plasma immunoreactive endothelin concentration correlates with severity of coronary artery disease in patients with stable angina pectoris and normal ventricular function.
|
J Am Coll Cardiol
|
1996
|
0.77
|
103
|
Inflammatory biomarkers of coronary atheromatous plaque vulnerability.
|
Panminerva Med
|
2005
|
0.77
|
104
|
The relationship between change and initial value: the continuing problem of regression to the mean.
|
Eur Heart J
|
1995
|
0.77
|
105
|
Key references on coronary artery spasm.
|
Circulation
|
1994
|
0.77
|
106
|
Detection of Chlamydia pneumoniae in atherosclerotic tissue: a comparative study of PCR and immunocytochemistry.
|
Br J Biomed Sci
|
2005
|
0.77
|
107
|
Chronic infections and coronary heart disease.
|
Int J Clin Pract
|
1999
|
0.77
|
108
|
Recovery-phase patterns of ST segment depression in the heart rate domain cannot distinguish between anginal patients with coronary artery disease and patients with syndrome X.
|
Am Heart J
|
1991
|
0.76
|
109
|
Improved coronary supply: prevailing mechanism of action of nitrates in chronic stable angina.
|
Am Heart J
|
1985
|
0.76
|
110
|
Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
|
Am Heart J
|
1984
|
0.76
|
111
|
Cardiac imaging in syndrome X: the problem of "reverse redistribution'.
|
Eur Heart J
|
1996
|
0.76
|
112
|
Release of platelet activation markers during coronary angioplasty.
|
Coron Artery Dis
|
2000
|
0.76
|
113
|
Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris.
|
Am Heart J
|
1998
|
0.76
|
114
|
Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.
|
Heart
|
2005
|
0.76
|
115
|
Serum endothelin levels and pain perception in patients with cardiac syndrome X and in healthy controls.
|
Am J Cardiol
|
1997
|
0.75
|
116
|
C-reactive protein as a clinical marker of risk.
|
Circulation
|
2000
|
0.75
|
117
|
'Comments on circulating transforming growth factor beta 1 and coronary artery disease'.
|
Cardiovasc Res
|
1998
|
0.75
|
118
|
Local cytokine production and acute coronary events.
|
Int J Cardiol
|
2000
|
0.75
|
119
|
Refractory variant angina relieved by guanethidine and clonidine.
|
Am J Cardiol
|
1988
|
0.75
|
120
|
Increased neopterin in patients with chronic and acute coronary syndromes.
|
J Am Coll Cardiol
|
1998
|
0.75
|
121
|
Treatment of stable angina pectoris: is there a role for dipyridamole?
|
Eur Heart J
|
2001
|
0.75
|
122
|
Chronic infection and atherogenesis.
|
Eur Heart J
|
1998
|
0.75
|
123
|
[3H]bosentan binding to human coronary artery: functional correlates.
|
J Cardiovasc Pharmacol
|
1995
|
0.75
|
124
|
Polymorphism in apolipoprotein(a) kringle IV 37(Met/Thr): frequency in a London population and its association with coronary artery disease.
|
Clin Cardiol
|
1997
|
0.75
|
125
|
A comparative study of eccentric and concentric coronary stenosis vasomotion in patients with Prinzmental's variant angina and patients with stable angina pectoris.
|
Clin Cardiol
|
1998
|
0.75
|
126
|
Factor V Leiden polymorphism (FV Q506) in patients with ischaemic heart disease, and in different populations groups.
|
J Hum Hypertens
|
1996
|
0.75
|
127
|
Duration of ST segment depression after exercise-induced myocardial ischemia is influenced by body position during recovery but not by type of exercise.
|
Am Heart J
|
1991
|
0.75
|
128
|
Statin treatment for all individuals with cholesterol concentrations above "target"?: "Primum non nocere"--Hippocratic oath.
|
Cardiovasc Drugs Ther
|
2012
|
0.75
|
129
|
Angiotensin-converting enzyme insertion/deletion polymorphism in angina pectoris with normal coronary arteriograms.
|
Am J Cardiol
|
1996
|
0.75
|
130
|
[Starting light alcohol drinking for prevention of coronary disease: too little too late?].
|
Herz
|
2002
|
0.75
|
131
|
Effects of theophylline, atenolol and their combination on myocardial ischemia in stable angina pectoris.
|
Am J Cardiol
|
1990
|
0.75
|
132
|
Similar time course of ST depression during and after exercise in patients with coronary artery disease and syndrome X.
|
Am Heart J
|
1990
|
0.75
|
133
|
Prediction of infarction-related artery occlusion and multivessel disease in postinfarction angina.
|
Int J Cardiol
|
2006
|
0.75
|
134
|
[Coronary artery spasm: physiopathology and clinical presentation].
|
Rev Port Cardiol
|
1998
|
0.75
|
135
|
Assessment of high on-treatment platelet reactivity in patients with ischemic heart disease: concordance between the Multiplate and VerifyNow assays.
|
J Thromb Haemost
|
2013
|
0.75
|
136
|
A combination of electrocardiographic methods represents a further step toward the noninvasive identification of patients with syndrome X.
|
Am Heart J
|
1992
|
0.75
|
137
|
[Approach to coronary artery spasm].
|
Rev Port Cardiol
|
1998
|
0.75
|
138
|
Methylenetetrahydrofolate reductase polymorphism (C-677T) and coronary artery disease.
|
Clin Sci (Lond)
|
1998
|
0.75
|
139
|
Effects of diltiazem alone or with isosorbide dinitrate or with atenolol both acutely and chronically for stable angina pectoris.
|
Am J Cardiol
|
1989
|
0.75
|
140
|
Ischemic threshold varies in response to different types of exercise in patients with chronic stable angina.
|
Am Heart J
|
1989
|
0.75
|
141
|
[Secondary prevention of coronary artery disease: interaction between the hospital and outpatient clinic in or der to form successful, low-cost strategies].
|
Rev Port Cardiol
|
2000
|
0.75
|
142
|
Heart rate-independent prolongation of QTc interval in women with syndrome X.
|
Clin Cardiol
|
1997
|
0.75
|
143
|
Is amiodarone an ideal antiarrhythmic drug?
|
Pacing Clin Electrophysiol
|
1984
|
0.75
|
144
|
Endothelin-like immunoreactivity in atherosclerotic human coronary arteries.
|
J Cardiovasc Pharmacol
|
1995
|
0.75
|
145
|
Adenosine-induced chest pain in patients with silent and painful myocardial ischaemia: another clue to the importance of generalized defective perception of painful stimuli as a cause of silent ischaemia.
|
Eur Heart J
|
1988
|
0.75
|
146
|
[Acute coronary infarcts: close connection between inflammation and thrombosis].
|
Herz
|
2002
|
0.75
|
147
|
Endothelial dysfunction in the absence of coronary atheroma causing Prinzmetal's angina.
|
Heart
|
1997
|
0.75
|
148
|
[The polymorphism of the angiotensin I-converting enzyme gene and its association with ischemic cardiopathy].
|
Rev Esp Cardiol
|
1996
|
0.75
|
149
|
[Progress in the knowledge on endothelial dysfunction and its application in clinical practice].
|
Rev Esp Cardiol
|
2001
|
0.75
|
150
|
[The diagnosis of myocardial damage during coronary angioplasty by the analysis of the isoforms of the enzyme creatine kinase MB].
|
Rev Esp Cardiol
|
1995
|
0.75
|
151
|
Long-term variability of angina pectoris and electrocardiographic signs of ischemia in syndrome X.
|
Am J Cardiol
|
1989
|
0.75
|
152
|
[Inflammation, infection and coronary artery disease: myths and realities. Special XXXV Conference of the National Congress of the Spanish Society of Cardiology].
|
Rev Esp Cardiol
|
2000
|
0.75
|
153
|
Patterns of coronary artery stenosis vasomotion: observed versus "predicted" stenosis reactivity in patients with chronic stable angina.
|
Coron Artery Dis
|
1993
|
0.75
|
154
|
Efficacy of amiodarone in patients with Chagas' disease and life-threatening arrhythmias.
|
Br J Clin Pract Suppl
|
1986
|
0.75
|
155
|
Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
|
J Heart Lung Transplant
|
1996
|
0.75
|